Analysis of 794,811 Indian insurance applicants reveals alarming cardiometabolic health patterns alongside systemic diagnostic failures. Among this working-age, urban population, 41.9% exhibited dyslipidemia and 61.4% met hypertension criteria—rates substantially higher than typical national surveys capture. More concerning, laboratory reference ranges varied so dramatically across 33,244 diagnostic centers that nearly half of prediabetes diagnoses would differ depending on which lab performed the test. This 49.7% disagreement rate at the critical 110 mg/dL fasting glucose threshold represents a diagnostic crisis undermining both individual patient care and population health tracking. The finding exposes how laboratory standardization failures create artificial disease prevalence variations across regions, potentially leading to misdiagnosis, inappropriate treatment decisions, and flawed public health policy. While this massive dataset provides unprecedented insights into India's cardiometabolic burden among economically active adults, the laboratory inconsistency findings have global implications for healthcare systems lacking unified diagnostic standards. As a preprint awaiting peer review, these results require validation, but the scale and consistency of the data suggest a paradigm-shifting revelation about diagnostic reliability in resource-variable healthcare systems.